Skip to main content
. 2019 Mar 21;19(5):4249–4255. doi: 10.3892/mmr.2019.10075

Figure 2.

Figure 2.

GSK 126 influences DNA-damaging agent-induced cell cycle redistribution. (A) RPMI8226 and (B) H929 cells were treated with GSK126 (5 µM), DOX (0.1 µM), MEL (10 µM) or a combination treatment for 48 h. Cell cycle distribution was established by flow cytometric evaluation. Data are representative of a minimum of three independent experiments. *P<0.05, **P<0.01. DOX, doxorubicin; MEL, melphalan.